| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1014476508 |
| P356 | DOI | 10.1007/S10620-010-1501-1 |
| P698 | PubMed publication ID | 21127976 |
| P2093 | author name string | Albert J Czaja | |
| P2860 | cites work | Antimitochondrial antibodies in acute liver failure: implications for primary biliary cirrhosis | Q24634370 |
| Long-term follow-up of antimitochondrial antibody-positive autoimmune hepatitis | Q28289028 | ||
| Chronic hepatitis B: update 2009 | Q29617409 | ||
| Diagnosis, management, and treatment of hepatitis C: an update | Q29619682 | ||
| International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis | Q33784003 | ||
| Variant forms of autoimmune hepatitis | Q34027622 | ||
| Diagnosis and management of autoimmune hepatitis | Q34118165 | ||
| Autoantibodies in liver disease | Q34157056 | ||
| LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase | Q34205552 | ||
| Immunologic features and HLA associations in chronic viral hepatitis | Q34314832 | ||
| Autoimmune hepatitis and its variant syndromes | Q34371115 | ||
| Variant syndromes of autoimmune hepatitis | Q34936633 | ||
| Liver/kidney microsomal antibody type 1 and liver cytosol antibody type 1 concentrations in type 2 autoimmune hepatitis | Q35351021 | ||
| Autoantibodies in the Diagnosis and Management of Liver Disease | Q35541984 | ||
| The validity and importance of subtypes in autoimmune hepatitis: a point of view | Q36690069 | ||
| The variant forms of autoimmune hepatitis | Q36820820 | ||
| Clinical features, differential diagnosis and treatment of autoimmune hepatitis in the elderly | Q37106402 | ||
| New diagnostic and treatment approaches in non-alcoholic fatty liver disease (NAFLD). | Q37437435 | ||
| Advances in the diagnosis, pathogenesis, and management of autoimmune hepatitis | Q37745609 | ||
| Autoantibodies as prognostic markers in autoimmune liver disease | Q37750545 | ||
| Autoantibodies in alcoholic liver disease | Q41236987 | ||
| Nuclear envelope protein autoantibodies in primary biliary cirrhosis | Q41412977 | ||
| Frequency and significance of antibodies to liver/kidney microsome type 1 in adults with chronic active hepatitis | Q42106972 | ||
| Features of autoimmune hepatitis in primary sclerosing cholangitis: an evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis | Q43948285 | ||
| Diagnosis and treatment of autoimmune hepatitis | Q44080061 | ||
| Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: a second type of "autoimmune" hepatitis | Q44086661 | ||
| Simplified criteria for the diagnosis of autoimmune hepatitis | Q44425899 | ||
| Prevalence and significance of autoantibodies in patients with non-alcoholic steatohepatitis | Q45057460 | ||
| Non-organ specific autoantibodies associated with chronic C virus hepatitis. | Q45777834 | ||
| Liver/kidney microsome antibody type 1 and hepatitis C virus infection | Q45872748 | ||
| New ELISA for detecting primary biliary cirrhosis-specific antimitochondrial antibodies. | Q46098794 | ||
| The prevalence of autoantibodies and autoimmune hepatitis in patients with nonalcoholic Fatty liver disease | Q47249864 | ||
| Immune phenotype of chronic liver disease | Q50864814 | ||
| Diagnosis and management of primary sclerosing cholangitis | Q51726466 | ||
| Alcoholic liver disease | Q51764048 | ||
| Detection of antinuclear antibodies: comparative evaluation of enzyme immunoassay and indirect immunofluorescence methods | Q52231259 | ||
| Performance parameters of the diagnostic scoring systems for autoimmune hepatitis | Q53207120 | ||
| Frequency, behavior, and prognostic implications of antimitochondrial antibodies in type 1 autoimmune hepatitis. | Q53458855 | ||
| Antibodies to soluble liver antigen, P450IID6, and mitochondrial complexes in chronic hepatitis | Q53741912 | ||
| Primary biliary cirrhosis | Q56428273 | ||
| PBC Screen: An IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis | Q59384457 | ||
| Non-Organ-Specific Autoantibodies in Nonalcoholic Fatty Liver Disease: Prevalence and Correlates | Q61854276 | ||
| Diversity of autoantibodies in primary biliary cirrhosis and chronic active hepatitis | Q70331416 | ||
| Patterns of nuclear immunofluorescence and reactivities to recombinant nuclear antigens in autoimmune hepatitis | Q72036043 | ||
| Sensitivity, specificity, and predictability of biopsy interpretations in chronic hepatitis | Q72638615 | ||
| High sensitivity of a novel ELISA for anti-M2 in primary biliary cirrhosis | Q73519599 | ||
| Antinuclear antibodies and patterns of nuclear immunofluorescence in type 1 autoimmune hepatitis | Q73671708 | ||
| Shared genetic risk factors in autoimmune liver disease | Q73676554 | ||
| Gender effects and synergisms with histocompatibility leukocyte antigens in type 1 autoimmune hepatitis | Q74637187 | ||
| Frequency and nature of the variant syndromes of autoimmune liver disease | Q77058224 | ||
| Host- and disease-specific factors affecting steatosis in chronic hepatitis C | Q77169958 | ||
| Behavior and significance of autoantibodies in type 1 autoimmune hepatitis | Q77221650 | ||
| Presence of antimitochondrial autoantibodies in patients with autoimmune hepatitis | Q80119655 | ||
| Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group | Q80820259 | ||
| The value of antinuclear antibodies in primary biliary cirrhosis | Q81008540 | ||
| Clinical implications of antimitochondrial antibodies in type 1 autoimmune hepatitis: a longitudinal study | Q81346473 | ||
| The role of autoantibodies as diagnostic markers of autoimmune hepatitis | Q84238571 | ||
| P433 | issue | 2 | |
| P921 | main subject | autoimmune hepatitis | Q786844 |
| P304 | page(s) | 545-554 | |
| P577 | publication date | 2010-12-03 | |
| P1433 | published in | Digestive Diseases and Sciences | Q15716711 |
| P1476 | title | Performance parameters of the conventional serological markers for autoimmune hepatitis | |
| P478 | volume | 56 |
| Q38054513 | Acute and Acute Severe (Fulminant) Autoimmune Hepatitis |
| Q37970311 | Autoantibody-Negative Autoimmune Hepatitis |
| Q92314377 | Autoimmune Hepatitis-Immunologically Triggered Liver Pathogenesis-Diagnostic and Therapeutic Strategies |
| Q90093431 | Autoimmune Hepatitis: Surviving Crises of Doubt and Elimination |
| Q59349440 | Autoimmune hepatitis |
| Q86886381 | Autoimmune hepatitis |
| Q37960961 | Autoimmune hepatitis in special patient populations |
| Q60932817 | Autoimmune hepatitis: Appraisal of current treatment guidelines |
| Q84967393 | Clinical significance of conventional serum autoantibodies for various liver diseases in a Chinese population |
| Q37885803 | Cryptogenic chronic hepatitis and its changing guise in adults |
| Q38609184 | Current concepts in the diagnosis and management of autoimmune hepatitis |
| Q28076505 | Diagnosis and Management of Autoimmune Hepatitis: Current Status and Future Directions |
| Q37969669 | Diagnosis and Treatment of Autoimmune Hepatitis |
| Q92166689 | Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American Association for the study of liver diseases |
| Q27003179 | Diagnosis and management of the overlap syndromes of autoimmune hepatitis |
| Q37843783 | Drug-Induced Autoimmune-Like Hepatitis |
| Q91935600 | Examining pathogenic concepts of autoimmune hepatitis for cues to future investigations and interventions |
| Q39436336 | Global Disparities and Their Implications in the Occurrence and Outcome of Autoimmune Hepatitis |
| Q61455279 | High Seroprevalence of Autoantibodies Typical of Autoimmune Liver Disease in Eastern Ethiopia: Is Chewing of Khat (Catha edulis) a Triggering Factor? |
| Q57137307 | Human leucocyte antigens and pediatric autoimmune liver disease: diagnosis and prognosis |
| Q86600713 | Liver Biopsy in the Management of Autoimmune Hepatitis Acute Severe Onset |
| Q35458645 | Non-invasive serum fibrosis markers: A study in chronic hepatitis. |
| Q60953544 | Role of Biologics in the Development of Autoimmune Hepatitis: A Review |
| Q91841670 | The Saudi association for the study of liver diseases and transplantation clinical practice guidelines for management of autoimmune hepatitis |
| Q38037392 | The overlap syndromes of autoimmune hepatitis |
| Q38496935 | Transitioning from Idiopathic to Explainable Autoimmune Hepatitis |
Search more.